Home About us Contact Us
Home Career News Gallery Inquiry Contact Us
Glibenclamide Bp Gujarat
  • Antibacterial/UTI Infection
    • Nalidixic Acid IP/BP/EP/USP (CEP No. R0-CEP 2012-005-Rev 00 )
  • Anti Diabetic
    • Glibenclamide/Glyburide IP/BP/EP/USP (RO-CEP 2012-042-Rev 00 )
  • Neuropathic Pain (CNS)
    • Pregabalin IP/IH
  • 3-Isobutylglutaric acid, [CAS No: 75143-89-4] CMH Diacid-Pregabalin Intermediate at MT Scale
  • 5-Chloro-2-methoxy-n-[2-(4 sulfamoylphenyl) Ethyl] benzamide-Glibenclamide/Glyburide Intermediate at MT Scale
  • RS-(3-Cabamoylmethyl)-5-Methylhexanoic Acid [CAS No:181289-52-7 or 181289-15-6] for Pregabalin at MT Scale
  • R-(-)-3-(carbamoylmethyl)-5-methylhexanoic acid, [181289-33-8] for Pregabalin at MT Scale
  • 2-(chloromethyl)-4-methylquinazoline having CAS No: 109113-72-6 for Linagliptin at Kilo Scale



  • Fexofenadine
  • Linagliptin
  • Dabigatran


  • 8-bromo-7-(but-2-yn-1-yl)-3-methyl-3,4,5,7-tetrahydro-1H-purin-2,6-dione CAS No : 666816-98-4 for Linagliptin
  • 2-(4-Cyanophenylamino) acetic acid CAS No [42288-26-6] for Dabigartan
  • 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino] propionic acid ethyl ester CAS No: [212322-56-0] for Dabigartan
  • Dibenzo b f 1 4 Thiazepin 11 10h one CAS No. 3159-07-7 for Quetiapine
  • 5-Bromo-2-Chlorobenzoic Acid CAS No 21739-92-4 for Empagliflozin/Dapagliflozin

Note : Above products will NOT be supplied to countries in which these could be in conflict with existing patents and the above products will only be offered to the extent that they will be used to obtain marketing approval and not for any commercial use. However, the final responsibility lies exclusively with the buyer